Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Transfusion Burden and Outcomes in Patients with Low- or Unspecified-Grade Myelodysplastic Syndromes Treated with Erythropoiesis-Stimulating Agents: Analysis of a United States Commercial Claims Database

Maneesha Mehra, Ravi Potluri, Jianming He, Aleksandra Rizo, Suneel Mundle, Jacqueline Bussolari

Blood (2016) 128 (22): 5974.

https://doi.org/10.1182/blood.V128.22.5974.5974

Published: 2016

Journal Articles

Characterization of Disease, Treatment Patterns, and Outcomes of Patients with Myelofibrosis: Analysis of 2 United States Commercial Claims Databases

Maneesha Mehra, Ravi Potluri, Jianming He, Grace Wang, Suneel Mundle, Jacqueline Bussolari

Blood (2016) 128 (22): 4769.

https://doi.org/10.1182/blood.V128.22.4769.4769

Published: 2016

Journal Articles

Relationship Between Epoetin Alfa (EPO) Treatment and Serum Hepcidin Levels in Anemic Patients with Rheumatoid Arthritis (RA)

Victor Moyo, MD, Robert Kersting, PharmD, Mark Westerman, PhD, Wayne Langholff, PhD, Ruchi Rastogi, PharmD, Suneel Mundle, PhD

Blood (2008) 112 (11): 3450.

https://doi.org/10.1182/blood.V112.11.3450.3450

Published: 2008

Journal Articles

Higher Erythroid Response Rates with Epoetin Alfa Versus Other Agents in Treatment-Naïve Low/Int-1 Myelodysplastic Syndrome Patients: A Comparative Meta-Analysis

Suneel Mundle, PhD, Patrick Lefebvre, MA, Francis Vekeman, MA, Mei Sheng Duh, MPH, ScD, François Laliberté, MA, Ruchi Rastogi, PharmD, Victor Moyo, MD

Blood (2008) 112 (11): 5074.

https://doi.org/10.1182/blood.V112.11.5074.5074

Published: 2008

Journal Articles

Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.

Suneel Mundle, PhD, Patrick Lefebvre, MA, Mei S. Duh, ScD, MPH, Francis Vekeman, MA, Behin Yektashenas, PharmD, Francois Laliberté, MA, Victor Moyo, MD

Blood (2007) 110 (11): 1471.

https://doi.org/10.1182/blood.V110.11.1471.1471

Published: 2007

Journal Articles

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Robert Orlowski, MD, PhD, Heather Sutherland, MD, PhD, Joan Bladé, MD, Jesús San Miguel, MD, Roman Hájek, MD, PhD, Arnon Nagler, MD, MSc, Pieter Sonneveld, MD, PhD, Andrew Spencer, DM, Tadeusz Robak, MD, PhD, Suneel Mundle, PhD, Donghan Luo, PhD, Sen Hong Zhuang, MD, PhD, Jean-Luc Harousseau, MD

Blood (2007) 110 (11): 2735.

https://doi.org/10.1182/blood.V110.11.2735.2735

Published: 2007

Journal Articles

Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Epoetin Alfa (EPO) or Darbepoetin Alfa (DARB) Using International Working Group Response Criteria (IWGc): Comparative Meta-Analysis.

Suneel Mundle, PhD, Patrick Lefebvre, MA, Mei S. Duh, MPH, ScD, Ahmed Bourezak, MA, Behin Yektashenas, PharmD, Victor Moyo, MD

Blood (2006) 108 (11): 2672.

https://doi.org/10.1182/blood.V108.11.2672.2672

Published: 2006

Journal Articles

Comparison of Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Different Therapeutic Strategies Using Epoetin Alfa (EPO).

Victor Moyo, MD, Patrick Lefebvre, MA, Ahmed Bourezak, MA, Behin Yektashenas, PharmD, Suneel Mundle, PhD

Blood (2006) 108 (11): 4839.

https://doi.org/10.1182/blood.V108.11.4839.4839

Published: 2006

Journal Articles

Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates

Vilasini Shetty, Seema Hussaini, LaTanya Broady-Robinson, Krishnan Allampallam, Suneel Mundle, Raphael Borok, Eileen Broderick, Lucia Mazzoran, Francesca Zorat, Azra Raza

Blood (2000) 96 (4): 1388–1392.

https://doi.org/10.1182/blood.V96.4.1388

Published: 2000

NARROW

Transfusion Burden and Outcomes in Patients with Low- or Unspecified-Grade Myelodysplastic Syndromes Treated with Erythropoiesis-Stimulating Agents: Analysis of a United States Commercial Claims Database

Characterization of Disease, Treatment Patterns, and Outcomes of Patients with Myelofibrosis: Analysis of 2 United States Commercial Claims Databases

Relationship Between Epoetin Alfa (EPO) Treatment and Serum Hepcidin Levels in Anemic Patients with Rheumatoid Arthritis (RA)

Higher Erythroid Response Rates with Epoetin Alfa Versus Other Agents in Treatment-Naïve Low/Int-1 Myelodysplastic Syndrome Patients: A Comparative Meta-Analysis

Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Epoetin Alfa (EPO) or Darbepoetin Alfa (DARB) Using International Working Group Response Criteria (IWGc): Comparative Meta-Analysis.

Comparison of Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Different Therapeutic Strategies Using Epoetin Alfa (EPO).

Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only